US Patent 7691585 Human Zven polypeptides
Patent 7691585 was granted and assigned to ZymoGenetics on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+380 characters)
Article
Patent abstract
The present invention provides polypeptides and compositions comprising amino acid residues 23 to 108 of SEQ ID NO: 2, polypeptides and compositions comprising amino acid residues 28 to 108 of SEQ ID NO: 2, including affinity tags and the like, useful for stimulating gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07691585 Human Zven polypeptides US Patent 7691585 Human Zven polypeptides
Infobox
Patent Number
0769158500
Patent Number
769158500
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076915850
Date of Patent
April 6, 2010
0Patent Application Number
115492410
Date Filed
October 13, 2006
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076915850
Date of Patent
April 6, 2010
0Patent Application Number
115492410
Date Filed
October 13, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07691585 Human Zven polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07691585
Date of patent
April 6, 2010
Patent application number
11549241
Date Filed
October 13, 2006
Patent primary examiner
Find more entities like US Patent 7691585 Human Zven polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.